| LCMNX | LMCMX | LCMNX / LMCMX | |
| Total Expense Ratio | 1.98 | 0.91 | 218% |
| Annual Report Gross Expense Ratio | 2.13 | 1.06 | 201% |
| Fund Existence | 12 years | 12 years | - |
| Gain YTD | 3.277 | 4.209 | 78% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 161M | 161M | 100% |
| Annual Yield % from dividends | 3.01 | 5.00 | 60% |
| Returns for 1 year | 0.83 | 2.00 | 41% |
| Returns for 3 years | 46.07 | 50.48 | 91% |
| Returns for 5 years | 57.02 | 64.50 | 88% |
| Returns for 10 years | 85.86 | 103.79 | 83% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SAHMX | 17.67 | 0.02 | +0.11% |
| SA International Value | |||
| SHSKX | 72.45 | -0.17 | -0.23% |
| BlackRock Health Sciences Opps K | |||
| AEDMX | 15.20 | -0.13 | -0.85% |
| American Century Emerging Markets R6 | |||
| SBIEX | 13.70 | -0.16 | -1.15% |
| ClearBridge International Value A | |||
| NEQAX | 12.93 | -0.21 | -1.60% |
| Neuberger Berman U.S. Equity Impact A | |||